Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test device
On Jun. 11, 2021, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition to the Sofiaᆴ and Sofiaᆴ 2 line of Fluorescent Immunoassay Analyzers (FIA).
Tags:
Source: NASDAQ
Credit: